3-Chloro-6-(1H-pyrazol-4-yl)pyridazine, 95.0%, 250mg

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide, 95.0%, 5g

3-Chloro-4-(3-fluorobenzyloxy)aniline>98.0%(GC)(T)1g

4-(4-BROMO-2,5-DIMETHYLPHENYL)BUTANOIC ACID, 95.0%, 25g

1,2,3,4-Tetrahydro-1,4-epiminonaphthalene hydrochloride, 95%, 250mg

4,4-Difluoro-1-(2-methylpropyl)cyclohexane-1-carboxylic acid, 1g

N-[3-[4,5-Dihydro-4-methyl-6-[[4-(4-morpholinylcarbonyl)phenyl]amino]-5-oxo-2-pyrazinyl]-2-methylphenyl]-4-(1,1-dimethylethyl)benzamide, 98%, 50mg

1-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)-1H-1,2,3-TRIAZOLE, 95.0%, 1g

3-Chloro-4,5-difluoro-benzoic acid, 95.0%, 5g

Single-channel microliter pipette Pipetman® G, 100 to 1000 µl, P1000G, 1 piece

1-Vinyl-1H-imidazole, 95.0%, 100g

3,5-Dichloro-4-(trifluoromethyl)benzenamine, 98%, 250mg

5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-2-amine, 95.0%, 10g